{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:15:48Z","timestamp":1783354548720,"version":"3.54.6"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jgo.2026.103007","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:49:26Z","timestamp":1778881766000},"page":"103007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation of a large language model as a decision tool for drug interaction in prostate cancer: A comparative study against UpToDate. Meet-URO 5\/25 - GENIE study"],"prefix":"10.1016","volume":"17","author":[{"given":"Simone","family":"Rota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto E.","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Dri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Bortolus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zambotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Congi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Pretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandro","family":"Membrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Di Civita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Cursano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Zanardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Verzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Gusmaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2026.103007_bb0005","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3390\/jcm14082565","article-title":"Advances in current treatment paradigms for metastatic hormone-sensitive prostate cancer","volume":"14","author":"Smani","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.jgo.2026.103007_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102525","article-title":"nmCRPC, a look in the continuous care of prostate cancer patients: state of art and future perspectives","volume":"115","author":"Berruti","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jgo.2026.103007_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231217958","article-title":"A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)","volume":"16","author":"Sepe","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jgo.2026.103007_bb0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/14737140.2025.2481141","article-title":"Current androgen receptor antagonists under investigation for resistant prostate cancer: progress and challenges","volume":"25","author":"Danielli","year":"2025","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.jgo.2026.103007_bb0025","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1464-410X.2012.10970.x","article-title":"The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes","volume":"110","author":"Magnani","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.jgo.2026.103007_bb0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1470-2045(22)00017-1","volume":"23","author":"Thiery-Vuillemin","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2026.103007_bb0035","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/annonc\/mdq761","article-title":"Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method","volume":"22","author":"van Leeuwen","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2026.103007_bb0040","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1186\/s12885-018-5076-0","article-title":"Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials","volume":"18","author":"Marcath","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgo.2026.103007_bb0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/bjc.2013.48","article-title":"Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs","volume":"108","author":"van Leeuwen","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2026.103007_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12877-025-05965-y","article-title":"Potential drug-drug interactions among geriatric oncology patients: a retrospective study in Saudi Arabia","volume":"25","author":"Alkathiri","year":"2025","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.jgo.2026.103007_bb0055","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyaf038","article-title":"Medical accuracy of artificial intelligence chatbots in oncology: a scoping review","volume":"30","author":"Chen","year":"2025","journal-title":"Oncologist"},{"key":"10.1016\/j.jgo.2026.103007_bb0060","doi-asserted-by":"crossref","DOI":"10.1177\/20420986251339358","article-title":"Can large language models detect drug-drug interactions leading to adverse drug reactions?","volume":"16","author":"Sicard","year":"2025","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.jgo.2026.103007_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/DHPS.S425858","article-title":"Evaluating the sensitivity, specificity, and accuracy of ChatGPT-3.5, ChatGPT-4, Bing AI, and Bard against conventional drug-drug interactions clinical tools","volume":"15","author":"Al-Ashwal","year":"2023","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.jgo.2026.103007_bb0070","first-page":"767","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"365","author":"Parker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2026.103007_bb0075","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1200\/JCO.2013.50.1684","article-title":"Phase I study of ARN-509, a novel antiandrogen, in the treatment of castration-resistant prostate cancer","volume":"31","author":"Rathkopf","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187940682600161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187940682600161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:29:42Z","timestamp":1783351782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187940682600161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S187940682600161X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2026.103007","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of a large language model as a decision tool for drug interaction in prostate cancer: A comparative study against UpToDate. Meet-URO 5\/25 - GENIE study","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2026.103007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103007"}}